Participants in research: Patients in clinical trials are protected by consumer regulation

Por Laurence, Desmond R
Publicado em 2005

Compensation for non-negligent harm in trials remains shaky

Por Laurence, Desmond R
Publicado em 2006

Engineering heat transfer. /

Por Karkelar, B. V., Desmond, R. M.
Publicado em 1977

Direct comparison of nick-joining activity of the nucleic acid ligases from bacteriophage T4

Por Bullard, Desmond R., Bowater, Richard P.
Publicado em 2006

Pumping the brakes on RAS – negative regulators and death effectors of RAS

Por Harrell Stewart, Desmond R., Clark, Geoffrey J.
Publicado no J Cell Sci (2020)

Transferencia de Calor /

Por Karlekar, B. V., Desmond, R. M., Galán Martínez, Arturo
Publicado em 1985

Variable Selection in Logistic Regression for Detecting SNP-SNP Interactions: the Rheumatoid Arthritis Example

Por Lin, H. Y., Desmond, R., Liu, Y. H., Bridges, S. L., Soong, S. J.
Publicado em 2008

The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer

Por Harrell Stewart, Desmond R., Schmidt, M. Lee, Donninger, Howard, Clark, Geoffrey J.
Publicado no Cancers (Basel) (2020)

Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy

Por Desmond, R. A., Accortt, N. A., Talley, L., Villano, S. A., Soong, S.-J., Whitley, R. J.
Publicado em 2006

A three-dimensional assay for measurement of viral-induced oncolysis

Por Lam, JT, Hemminki, A, Kanerva, A, Lee, KB, Blackwell, JL, Desmond, R, Siegal, GP, Curiel, DT
Publicado em 2007

Differential Modulation of Drug-Induced Structural and Functional Plasticity of Dendritic Spines

Por Miller, Eric C., Zhang, Lei, Dummer, Benjamin W., Cariveau, Desmond R., Loh, Horace, Law, Ping-Yee, Liao, Dezhi
Publicado em 2012

Reply to “Phase II prospective randomized trial of weight loss prior to radical prostatectomy”

Por Demark-Wahnefried, W., Rais-Bahrami, S., Desmond, R. A., Gordetsky, J. B., Azrad, M., Frugé, A. D., Yang, E. S., Norian, L. A., Grizzle, W. E.
Publicado no Prostate Cancer Prostatic Dis (2018)

Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome

Por Khoury, P., Desmond, R., Pabon, A., Holland-Thomas, N., Ware, J. M., Arthur, D. C., Kurlander, R., Fay, M. P., Maric, I., Klion, A. D.
Publicado no Allergy (2016)